There is a version of body fat that does not jiggle, cannot be pinched, and does not show up on the scale in a way that distinguishes it from any other weight. You cannot feel it with your fingers. You may look relatively slim and carry large quantities of it. Yet it is secreting inflammatory cytokines, disrupting your insulin signalling, coating your liver, squeezing your kidneys, and raising your risk of type 2 diabetes, cardiovascular disease, and dementia simultaneously. This is visceral fat – the fat stored deep inside your abdominal cavity, wrapped around your organs – and it is categorically more dangerous than the fat stored beneath your skin. Understanding the difference between visceral and subcutaneous fat is not an academic exercise. For Indians in particular, it is a matter of urgent clinical importance.
Key Takeaways
- Subcutaneous fat – the fat under your skin that you can pinch – is largely metabolically benign. It insulates and stores energy but does not significantly drive disease
- Visceral fat – fat surrounding your organs – is metabolically active. It releases inflammatory chemicals and disrupts insulin, liver function, and hormonal balance
- Indians accumulate more visceral fat at lower BMI than Western populations – the “thin-fat Indian” phenomenon means you can have dangerous organ fat with a normal-looking body
- A waist circumference above 90cm for men and 80cm for women (Asian-specific cutoffs) is a reliable proxy for dangerous visceral fat accumulation
- Visceral fat responds faster to exercise and dietary change than subcutaneous fat – it is metabolically active in both directions
What Is Subcutaneous Fat?
Subcutaneous fat is the fat layer directly beneath your skin – the fat you can grab, pinch, and see. It is distributed across the body: arms, thighs, buttocks, hips, and belly. It exists in everyone and serves important functions: insulation, energy storage, cushioning for bones, and in women, production of oestrogen.
Importantly, subcutaneous fat – even in large quantities – is not strongly associated with metabolic disease. Research has consistently shown that people who are obese primarily in the subcutaneous compartment (often described as “pear-shaped”) have significantly lower rates of diabetes, cardiovascular disease, and metabolic syndrome than equally heavy people who store fat viscerally. Some studies suggest that subcutaneous fat may even have protective metabolic properties, acting as a metabolic sink that buffers excess fatty acids from reaching organs.
What Is Visceral Fat?
Visceral fat is fat stored within the abdominal cavity – surrounding and infiltrating the liver, pancreas, kidneys, intestines, and heart. Unlike subcutaneous fat, it is not passive. Visceral fat is metabolically active tissue that secretes a range of biologically active molecules including:
- Inflammatory cytokines (IL-6, TNF-alpha) – which drive systemic low-grade inflammation, a root cause of insulin resistance, cardiovascular disease, and neuroinflammation linked to dementia
- Free fatty acids – released directly into the portal vein feeding the liver, promoting non-alcoholic fatty liver disease and disrupting hepatic insulin sensitivity
- Adipokines (leptin, adiponectin) – in imbalanced ratios that further worsen insulin signalling and energy regulation
This is why visceral fat is not just an energy storage problem – it is an active hormonal and inflammatory organ.
The Indian Visceral Fat Problem – Why This Is Especially Urgent
The Thin-Fat Indian: Why BMI Misleads South Asians
Indians have more visceral fat at any given BMI than Western populations. Multiple imaging studies show that at equivalent BMIs, South Asians have significantly higher visceral fat volume and lower muscle mass – a body composition pattern termed “metabolically obese normal weight” or the “thin-fat Indian” phenotype.
Standard BMI cut-offs miss millions of at-risk Indians. A BMI below 25 – “normal” by global standards – can mask dangerous visceral fat accumulation in South Asian individuals. WHO revised Asian-specific cut-offs to 23 for overweight, recognising this metabolic difference.
This explains India’s disproportionate diabetes burden. India has over 101 million people with type 2 diabetes – more than any country in the world – yet average BMI in India is substantially lower than in Western nations with comparable or lower diabetes rates. Visceral fat, not total body weight, is the driver.
How to Measure Your Visceral Fat Risk Without a Scan
DEXA scans and CT imaging can quantify visceral fat precisely, but they are expensive and not routinely available. The best accessible proxies are:
- Waist circumference: Measure at the navel. Risk thresholds for South Asians: men above 90cm, women above 80cm. This is more predictive than BMI alone.
- Waist-to-height ratio: Divide waist circumference by height. A ratio above 0.5 indicates excess central adiposity. Simple, BMI-independent, and highly predictive of metabolic risk.
- Waist-to-hip ratio: Men above 0.90, women above 0.85 – indicates central fat distribution pattern linked to visceral accumulation.
- Fasting insulin level: Elevated fasting insulin (above 10-12 uIU/mL) is a reliable indirect marker of visceral fat-driven insulin resistance.
How to Target Visceral Fat Specifically
Visceral fat responds faster to intervention than subcutaneous fat – because it is metabolically active, it can be mobilised relatively quickly with the right stimulus.
The interventions with the strongest evidence:
- Aerobic exercise: Zone 2 cardio (moderate-intensity sustained exercise) is the most effective intervention for visceral fat reduction – studies show 30-45 minutes five days per week reduces visceral fat significantly within 12 weeks, even without substantial weight loss
- Caloric reduction with protein priority: Reducing refined carbohydrate intake (particularly rice, white bread, sugary beverages) reduces the insulin-driven fat storage pattern that preferentially deposits visceral fat
- Sleep optimisation: Poor sleep directly increases cortisol, which specifically drives visceral fat accumulation – not subcutaneous fat
- Stress management: Chronic cortisol elevation from psychological stress is a major driver of visceral fat – independent of diet and exercise
- GLP-1 drugs (medically supervised): Semaglutide and tirzepatide show preferential reduction in visceral fat – multiple imaging trials confirm greater visceral than subcutaneous fat loss
For metabolic support alongside diet and exercise, berberine improves insulin sensitivity through the same cellular pathway as metformin – directly targeting the insulin resistance mechanism that drives visceral fat accumulation. Multiple clinical trials show berberine reduces fasting blood glucose, insulin levels, and waist circumference. Check out this metabolic support supplement on Amazon.in – formulated to support healthy blood sugar and fat metabolism.
Related: India’s Obesity Crisis – The Numbers That Should Alarm Every Indian
The thin-fat Indian phenomenon is driving a diabetes crisis at a scale the world has never seen. Read the full picture: India’s Obesity Crisis: The Numbers That Should Alarm Every Indian
Dr. Ajit Jha’s Clinical Perspective
“The distinction between visceral and subcutaneous fat is one I wish every patient understood before they walked into my clinic. I regularly see patients who tell me they are not worried about their weight because they do not look overweight – and then I measure their waist circumference and test their fasting insulin and find exactly the metabolic picture I was afraid of. In India, this is not an edge case. The thin-fat Indian phenotype is the norm, not the exception. I want people to understand that the number on the scale is not the health measurement that matters most. Waist circumference, fasting insulin, and your HbA1c together give you a far more honest picture of your visceral fat burden and your metabolic health. The good news is visceral fat is the most responsive type of fat to lifestyle intervention. Unlike subcutaneous fat which can take years to move significantly, visceral fat begins reducing within weeks of consistent aerobic exercise and dietary carbohydrate reduction. You can make meaningful progress faster than you think.”
– Dr. Ajit Jha, MD Medicine | IMA Lifetime Member | Editorial Board Member, International Journal of Diabetes and Endocrinology (IJDE)
Frequently Asked Questions
Can you feel visceral fat?
No. Visceral fat is located deep within the abdominal cavity, behind the abdominal muscles. You cannot feel it when you press on your stomach. The fat you can pinch on your belly is subcutaneous fat – which is far less metabolically dangerous. Visceral fat can only be measured accurately with imaging (DEXA, CT, MRI), though waist circumference and waist-to-height ratio provide reliable clinical proxies.
Is belly fat always visceral fat?
Not necessarily. Both visceral and subcutaneous fat contribute to belly size – and most people with a large belly have both types. The ratio matters: a hard, protruding belly (“pot belly”) with relatively little pinchable fat tends to indicate more visceral fat. A soft, pinchable belly tends to have more subcutaneous fat. Neither is desirable in excess, but visceral fat is the clinically more dangerous component.
How long does it take to reduce visceral fat?
Visceral fat responds faster than subcutaneous fat. Studies show measurable visceral fat reduction within 4 to 12 weeks of consistent aerobic exercise (30-45 minutes, 5 days per week) and caloric deficit, even without major changes in total body weight or subcutaneous fat. The first fat your body mobilises with energy deficit tends to be visceral – making it more responsive to intervention than the fat you can see.
What is the most accurate test for visceral fat in India?
DEXA scan provides a good visceral fat estimate and is available at major diagnostic centres in Indian cities. MRI is more accurate but expensive and less accessible. CT scan is accurate but involves radiation. For most people, waist circumference plus fasting insulin level provides a clinically meaningful and accessible assessment of visceral fat risk – no imaging required.
📖 Related Articles